Jawaher Ansari

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

Matteo Santoni, Sebastiano Buti, Zin Myint et al. · European Urology Oncology · 2023 · 52 citations · Full text

Differential Effectiveness, Urology, Genitourinary Cancer +7

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2024 · 43 citations · Full text

Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study

Matteo Santoni, Francesco Massari, Zin Myint et al. · Targeted Oncology · 2023 · 34 citations · Full text

Immuno-oncology Combinations, Urology, Kidney Transplant +7

The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force.

Humaid O. Al‐Shamsi, Humaa Darr, Ibrahim Abu-Gheida et al. · PubMed · 2020 · 33 citations

Oncology, Cancer Epidemiology, Health Policy +15

Efficacy of Nivolumab in a Patient with Metastatic Renal Cell Carcinoma and End-Stage Renal Disease on Dialysis: Case Report and Literature Review

Jawaher Ansari, Muhammad Ali, Ashraf Farrag et al. · Case Reports in Immunology · 2018 · 32 citations · Full text

Immunology, Retrospective Case Studies, Dialysis Therapy +16